Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 3;9(4):a022145.
doi: 10.1101/cshperspect.a022145.

TGF-β Family Signaling in the Control of Cell Proliferation and Survival

Affiliations
Review

TGF-β Family Signaling in the Control of Cell Proliferation and Survival

Yun Zhang et al. Cold Spring Harb Perspect Biol. .

Abstract

The transforming growth factor β (TGF-β) family controls many fundamental aspects of cellular behavior. With advances in the molecular details of the TGF-β signaling cascade and its cross talk with other signaling pathways, we now have a more coherent understanding of the cytostatic program induced by TGF-β. However, the molecular mechanisms are still largely elusive for other cellular processes that are regulated by TGF-β and determine a cell's proliferation and survival, apoptosis, dormancy, autophagy, and senescence. The difficulty in defining TGF-β's roles partly stems from the context-dependent nature of TGF-β signaling. Here, we review our current understanding and recent progress on the biological effects of TGF-β at the cellular level, with the hope of providing a framework for understanding how cells respond to TGF-β signals in specific contexts, and why disruption of such mechanisms may result in different human diseases including cancer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The transforming growth factor β (TGF-β) signaling pathway and its context-dependent regulation. (Left) A schematic diagram of TGF-β signaling. (Right) TGF-β signaling is regulated at several levels by context-dependent factors: (1) Different combinations of paired type I and type II receptors allow for diverse ligand binding as well as intracellular signaling. (2) Accessory proteins at the plasma membrane that regulate the binding efficiency and specificity of TGF-β to their receptors influence downstream responses. (3) Proteins that regulate the recruitment and access of R-Smads to TGF-β receptors. (4) Several proteins regulate TGF-β signaling by posttranslational modification of R-Smads or by preventing their association with TGF-β receptors. (5) A specific TGF-β response can be determined by the expression and activity of transcription cofactors.
Figure 2.
Figure 2.
The transforming growth factor β (TGF-β)-mediated cytostatic program in epithelial cells. (A) TGF-β suppresses the expression of transcription factors that regulate growth control including those encoding c-Myc and Id family members. (B) TGF-β induces the expression of several cyclin-dependent kinase (CDK) inhibitors, including p15INK4B and p21CIP1. TGF-β also increases p27KIP1 activity without changing the transcription of CDKN1B gene, partly because increased p15INK4B disrupts existing p27KIP1-CDK4/6-cyclin D complexes. (C) TGF-β also suppresses cell-cycle progression by repressing the expression and activity of Cdc25A and inducing expression of 4EBP1.
Figure 3.
Figure 3.
A schematic diagram illustrating possible mechanisms of transforming growth factor β (TGF-β)-induced apoptosis. The displayed mechanisms are described in distinct cell types. The balance between TGF-β and phosphoinositide 3-kinase (PI3K)-Akt signaling is essential for determining whether a cell will undergo apoptosis in response to TGF-β.
Figure 4.
Figure 4.
Regulation of cellular senescence by transforming growth factor β (TGF-β) signaling. TGF-β family proteins are able to promote cellular senescence in normal and tumor cells through multiple molecular mechanisms, including transcriptional induction of the expression of cell-cycle inhibitors, repression of telomerase expression, and convergent regulation with the p53 pathway.

References

    1. Accili D, Arden KC. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421–426. - PubMed
    1. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, et al. 2013. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15: 978–990. - PMC - PubMed
    1. Aguirre-Ghiso JA. 2007. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7: 834–846. - PMC - PubMed
    1. Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al. 2009. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139: 757–769. - PMC - PubMed
    1. Alexandrow MG, Moses HL. 1995. Transforming growth factor β and cell cycle regulation. Cancer Res 55: 1452–1457. - PubMed

Substances